Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Lyrica (Viatris Inc.)
(https://lyrica.com) 📸 Data Snapshot: May 31, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE LYRICA® (pregabalin) CV (https://lyrica.com)
LYRICA® (pregabalin) CV
Description (Seen in organic search results, limited to 160 characters, including spaces) Official website of LYRICA® (pregabalin) Capsules CV. See risks and benefits of LYRICA.
NAV_HEADER_HEADING_REPEATED_BODY Sign up for LYRICA Updates | LYRICA® (pregabalin) CV (https://lyrica.com/sign-up/)
Sign up for LYRICA Updates | LYRICA® (pregabalin) CV
For people taking or considering LYRICA® (pregabalin) CV, sign up to get more information.
NAV_HEADER_HEADING_REPEATED LYRICA Savings Card Program | LYRICA® (pregabalin) CV (https://lyrica.com/savings-card/)
LYRICA Savings Card Program | LYRICA® (pregabalin) CV
Eligible patients may pay as little as $4 per LYRICA® (pregabalin) CV prescription. Terms and conditions apply.
NAV_HEADER_HEADING_REPEATED_BODY Fibromyalgia | LYRICA® (pregabalin) CV (https://lyrica.com/fm/)
Fibromyalgia | LYRICA® (pregabalin) CV
Find info on fibromyalgia, including symptoms, diagnosis, and treatment options. See LYRICA safety info & PI, including life-threatening, allergic reactions.
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE · THIN (https://lyrica.com) LYRICA® (pregabalin) CV
[H2] YOU ARE LEAVING LYRICA.COM, A VIATRIS INC. COMPANY WEBSITE Links to another site are provided as a convenience to the viewer.ContinueStay on Site [IMG: LYRICA (pregabalin) CV capsules] [H1] LYRICA may help you on your path to symptom relief LYRICA is FDA approved to treat: Fibromyalgia Diabetic Nerve Pain Spinal Cord Injury Nerve Pain Pain After Shingles Partial-Onset Seizures Not actual patients. Sign up for LYRICA updates Not actual patients. Sign up for LYRICA updates
SUB-PAGE · THIN (https://lyrica.com/sign-up/) Sign up for LYRICA Updates | LYRICA® (pregabalin) CV
[H2] YOU ARE LEAVING LYRICA.COM, A VIATRIS INC. COMPANY WEBSITE Links to another site are provided as a convenience to the viewer.ContinueStay on Site [H1] Sign Up for More Information
SUB-PAGE · THIN (https://lyrica.com/savings-card/) LYRICA Savings Card Program | LYRICA® (pregabalin) CV
[H2] YOU ARE LEAVING LYRICA.COM, A VIATRIS INC. COMPANY WEBSITE Links to another site are provided as a convenience to the viewer.ContinueStay on Site [H1] LYRICA Savings Card Eligible, commercially insured patients may pay as little as $4 per month for their LYRICA prescription.* *Terms and conditions apply. [IMG: LYRICA (pregabalin) Savings Card] YOUR SAVINGS, YOUR WAY Choose how to get your LYRICA Savings Card Download Email Text [IMG: LYRICA (pregabalin) Savings Card]
SUB-PAGE · THIN (https://lyrica.com/fm/) Fibromyalgia | LYRICA® (pregabalin) CV
[H2] YOU ARE LEAVING LYRICA.COM, A VIATRIS INC. COMPANY WEBSITE Links to another site are provided as a convenience to the viewer.ContinueStay on Site Not actual patient. [H1] FDA approved for the management of fibromyalgia painLYRICA may help ease your fibromyalgia pain [H1] FDA approved for the management of fibromyalgia painLYRICA may help ease your fibromyalgia pain [H3] WHAT IS FIBROMYALGIA? Learn about fibromyalgia, its symptoms, and ways to help manage it. [IMG: Starting LYRICA] [H3] START THE CONVERSATION Get helpful tips on how to talk to your healthcare provider about fibromyalgia pain. [H3] FIND ANSWERS Explore commonly asked questions about LYRICA, including information on dosing, side effects, and how it works.
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 1 | 1 |
| /sign-up/ | 1 | 1 |
| /savings-card/ | 1 | 1 |
| /fm/ | 1 | 1 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage schema
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"@id": "https://www.lyrica.com",
"url": "https://www.lyrica.com",
"inLanguage": "en-US",
"name": "LYRICA may help you on your path to symptom relief",
"description": "Learn about LYRICA and its FDA-approved uses, including fibromyalgia, diabetic nerve pain, spinal cord injury nerve pain, pain after shingles, and partial-onset seizures.",
"about": [
{
"@type": "MedicalCondition",
"name": "Fibromyalgia"
},
{
"@type": "MedicalCondition",
"name": "Diabetic nerve pain"
},
{
"@type": "MedicalCondition",
"name": "Spinal cord injury nerve pain"
},
{
"@type": "MedicalCondition",
"name": "Pain after shingles"
},
{
"@type": "MedicalCondition",
"name": "Partial-onset seizures"
}
],
"publisher": {
"@type": "Organization",
"name": "Viatris",
"url": "https://www.viatris.com",
"logo": {
"@type": "ImageObject",
"url": "https://www.viatris.com/-/media/project/common/viatris/viatris-logo_withouttm.svg"
}
},
"isPartOf": {
"@type": "WebSite",
"@id": "https://www.lyrica.com"
}
},
{
"@type": "Organization",
"name": "Viatris",
"url": "https://www.viatris.com",
"logo": {
"@type": "ImageObject",
"url": "https://www.viatris.com/-/media/project/common/viatris/viatris-logo_withouttm.svg"
}
},
{
"@type": "SiteNavigationElement",
"name": "Top navigation",
"inLanguage": "en-US",
"hasPart": [
{
"@type": "SiteNavigationElement",
"name": "Important Safety Information",
"url": "https://www.lyrica.com"
},
{
"@type": "SiteNavigationElement",
"name": "Full Prescribing Information",
"url": "https://www.lyrica.com"
},
{
"@type": "SiteNavigationElement",
"name": "Medication Guide",
"url": "https://www.lyrica.com"
}
]
},
{
"@type": "ItemList",
"name": "FDA-approved conditions treated with LYRICA",
"itemListOrder": "Unordered",
"numberOfItems": 5,
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Fibromyalgia"
},
{
"@type": "ListItem",
"position": 2,
"name": "Diabetic nerve pain"
},
{
"@type": "ListItem",
"position": 3,
"name": "Spinal cord injury nerve pain"
},
{
"@type": "ListItem",
"position": 4,
"name": "Pain after shingles"
},
{
"@type": "ListItem",
"position": 5,
"name": "Partial-onset seizures"
}
]
}
]
}
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: Lyrica (Viatris Inc.) (lyrica.com)
Lyrica.com is a high-authority pharmaceutical shell that prioritizes regulatory compliance and lead generation over substantive patient education. It scores as Moderate BS because while its claims are legally ‘safe,’ they are functionally hollow, offering users a $4 coupon in place of the clinical evidence required to substantiate its ‘path to relief’ messaging.
Immediate structural fixes are required, starting with moving the [H2] legal exit warnings out of the primary heading hierarchy so they do not precede the [H1]. Replace generic section headers like ‘Find Answers’ with substance-led headings such as ‘Clinical Trial Results for Fibromyalgia.’ Integrate specific outcome data, such as the percentage of trial participants who experienced significant pain reduction, directly into the disease-state sub-pages. Finally, clean the schema to remove the ‘review_count’ of 1 if there is no verifiable third-party review platform being utilized, as this triggers trust theatre red flags.
The content strictly adheres to pharmaceutical regulatory norms for a branded medication. The presence of Indication and Usage sections alongside Important Safety Information confirms its status in the Pharma & Biotech industry.
“The score of 45 is driven by high Information Density penalties due to thin content and Commodity Fingerprint penalties for generic pharma cliches. While Identity and Authority is strong due to the brand name, the structural messiness and lack of on-page clinical specifics prevent a lower BS score.”
This training module utilizes a snapshot of public data from Lyrica (Viatris Inc.), captured on May 31, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to Lyrica (Viatris Inc.): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://lyrica.com to view the most current version of its content and learn from the source what this company is about and what it offers.